Boston Scientific (BSX) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Boston Scientific Corporation  (NYSE: BSX)
 

Boston Scientific Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2026, Boston Scientific's inventory turnover ratio sequentially decreased to 2.06 in the third quarter 2026, unsurprisingly, as the Boston Scientific markets continue to deteriorate, and BSX's faces growing challenges to bring down its inventories. Boston Scientific's average inventory processing period in the Sep 30 2026 quarter, has increased to 177 days, from 176 days, in the Jun 30 2026 quarter.

Within Healthcare sector 194 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2026, to 1539, from total ranking in the second quarter 2026 at 1728.

BSX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Boston Scientific Corporation Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BSX Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth 13.56 % 13.07 % 8.72 % 4.73 % 6.1 %
Y / Y Cost of Sales Growth 12.28 % -2.63 % 9.43 % 9.69 % 16.08 %
Inventory Turnover Ratio (TTM) 2.06 2.07 2.15 2.15 2.12
BSX's Total Ranking # 1539 # 1728 # 1567 # 1587 # 1616
Average inventory processing period 177 177 170 170 172
Seq. Inventory Growth 2.53 % 3.79 % 5.91 % 0.75 % 2.1 %
Seq. Cost of Sales Growth 7.28 % 0.25 % -1.12 % 5.58 % -6.96 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 83
Healthcare Sector # 195
Overall Market # 1539

Inventory Turnover Ratio Statistics
High Average Low
3.46 2.53 1.77
(Sep. 30, 2005)   (March 31, 2014)



BSX Company Profile >> Back to BSX Efficiency Comparisons >> Compare BSX Inventory Turnover Ratio to its Competitors

Financial Statements
Boston Scientific's Inventories $ 3,317 Millions Visit BSX's Balance sheet
Boston Scientific's Cost of Revenues TTM $ 6,502 Millions Visit BSX's Income Statement
What are BSX's Sales? Visit BSX's Sales by Segment

Other Inventory Turnover Ratios
Boston Scientific's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BSX's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BSX's Competitors
Inventory Turnover Ratio for BSX's Suppliers
Inventory Turnover Ratio for BSX's Customers

You may also want to know
BSX's Sales Growth Rates BSX's Pe Price to earnings ratio BSX's Receivables Turnover Ratio BSX's Stock Quote
BSX's Net Income Growth Rates BSX's Ps Price to Sales ratio BSX's Sales per Employee BSX's Asset Turnover Ratio
BSX's Net Margin BSX's Pb Price to Book ratio BSX's Financial Strength Ratios BSX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Tactile Systems Technology Inc   5.25 $ 82.718  Millions$ 16  Millions
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Henry Schein Inc   4.63 $ 9,395.000  Millions$ 2,031  Millions
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions
Bausch Health Companies Inc   3.54 $ 4,518.000  Millions$ 1,276  Millions
Exelixis Inc   3.49 $ 93.324  Millions$ 27  Millions
Abbvie Inc   3.40 $ 17,346.000  Millions$ 5,108  Millions
Gilead Sciences Inc   3.30 $ 6,219.000  Millions$ 1,884  Millions
Teva Pharmaceutical Industries Limited  3.16 $ 8,011.000  Millions$ 2,537  Millions
Msa Safety Inc  3.00 $ 1,063.235  Millions$ 354  Millions
Mimedx Group Inc   2.98 $ 70.562  Millions$ 24  Millions
Ligand Pharmaceuticals Incorporated  2.93 $ 34.495  Millions$ 12  Millions
Neogen Corporation  2.89 $ 464.774  Millions$ 161  Millions
Zevra Therapeutics Inc   2.82 $ 6.736  Millions$ 2  Millions
Biomerica Inc   2.65 $ 4.297  Millions$ 2  Millions
Dexcom Inc   2.65 $ 1,867.500  Millions$ 705  Millions
Angiodynamics Inc   2.50 $ 142.709  Millions$ 57  Millions
Pro dex Inc   2.45 $ 53.753  Millions$ 22  Millions
Illumina Inc   2.36 $ 1,458.000  Millions$ 618  Millions
Mirum Pharmaceuticals Inc   2.35 $ 59.684  Millions$ 25  Millions
Aquestive Therapeutics Inc   2.34 $ 16.928  Millions$ 7  Millions
Resmed Inc   2.33 $ 2,214.675  Millions$ 952  Millions
Beta Bionics Inc   2.31 $ 53.285  Millions$ 23  Millions

Date modified: 2026-11-03T09:56:18+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.